Alamar Biosciences to Report First Quarter 2026 Financial Results on May 8, 2026
May 1, 2026 - 00:23
FREMONT, Calif., April 30, 2026 -- Alamar Biosciences, Inc., a company focused on precision proteomics and early disease detection, has announced it will release its financial results for the first quarter of 2026 before the market opens on Friday, May 8, 2026.
The company noted that its first earnings conference call as a publicly traded entity is currently planned for August 2026. That call will cover the financial results for the second quarter of the year.
Alamar Biosciences is working on technologies aimed at identifying disease at its earliest stages through protein analysis. The upcoming report will provide investors with a look at the company's performance for the first three months of 2026.
MORE NEWS
July 30, 2026 - 19:24
SEC chair defends proposal to allow companies to report earnings only twice a yearSecurities and Exchange Commission Chair Paul Atkins has pushed back against critics of a proposal that would allow publicly traded companies to report their financial results only twice a year,...
July 30, 2026 - 03:18
Finance firms set to pour more into AI amid ‘data divide’ fearsA new survey reveals that most asset management firms are gearing up to significantly increase their investments in artificial intelligence over the next year. The push comes as the industry...
July 29, 2026 - 19:01
ECU Health appoints Brian Dunn as chief financial officer, effective immediatelyECU Health has appointed Brian Dunn, a certified public accountant, as its new chief financial officer, effective immediately. The health system announced the leadership change, placing Dunn in...
July 29, 2026 - 04:45
Corporation Commission candidate Ralph Heap faces campaign-finance probeAs a result of the probe, Heap has been locked out of his public campaign funding. The Clean Elections Commission is reviewing the details of the sign purchases and whether they violated any state...